Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Christina Cox

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|November 24, 2020
Exercise training (ET) in adult and elderly patients receiving anti-lymphoma treatments is feasible and may improve the provision of careMaria Christina Cox, Sveva Maria Nusca, Francesca Di Landro, et al.
British Journal of Haematology|June 5, 2003
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Luca Maurillo, et al.
British Journal of Haematology|April 3, 2004
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemiasFrancesco Buccisano, Francesca Maria Rossi, Adriano Venditti, et al.
Hematological Oncology|August 8, 2015
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessmentEmanuele Cencini, Alberto Fabbri, Luigi Rigacci, et al.
In Vivo (Athens, Greece)|May 2, 2020
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective StudyVitaliana DE Sanctis, Alice DI Rocco, Maria Christina Cox, et al.
Leukemia & Lymphoma|December 16, 2015
Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter studyAnnalisa Arcari, Annalisa Chiappella, Michele Spina, et al.
International Journal of Laboratory Hematology|September 10, 2024
A new digital droplet PCR method for looking at epigenetics in diffuse large B-cell lymphomas: The role of BMI1, EZH2, and USP22 genesAlessio Lusci Gemignani, Robel Papotti, Riccardo Bomben, et al.
The Oncologist|March 22, 2006
Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease disseminationLuca Arcaini, Sara Burcheri, Andrea Rossi, et al.
European Journal of Cancer Care|October 2, 2019
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI networkMariavita Ciccarone, Stefan Hohaus, Alessandro Pulsoni, et al.
Leukemia & Lymphoma|March 8, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ studyAlessandra Tucci, Alessandro Re, Chiara Pagani, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|November 24, 2020
Exercise training (ET) in adult and elderly patients receiving anti-lymphoma treatments is feasible and may improve the provision of careMaria Christina Cox, Sveva Maria Nusca, Francesca Di Landro, et al.
British Journal of Haematology|June 5, 2003
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Luca Maurillo, et al.
British Journal of Haematology|April 3, 2004
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemiasFrancesco Buccisano, Francesca Maria Rossi, Adriano Venditti, et al.
Hematological Oncology|August 8, 2015
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessmentEmanuele Cencini, Alberto Fabbri, Luigi Rigacci, et al.
In Vivo (Athens, Greece)|May 2, 2020
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective StudyVitaliana DE Sanctis, Alice DI Rocco, Maria Christina Cox, et al.
Leukemia & Lymphoma|December 16, 2015
Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter studyAnnalisa Arcari, Annalisa Chiappella, Michele Spina, et al.
International Journal of Laboratory Hematology|September 10, 2024
A new digital droplet PCR method for looking at epigenetics in diffuse large B-cell lymphomas: The role of BMI1, EZH2, and USP22 genesAlessio Lusci Gemignani, Robel Papotti, Riccardo Bomben, et al.
The Oncologist|March 22, 2006
Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease disseminationLuca Arcaini, Sara Burcheri, Andrea Rossi, et al.
European Journal of Cancer Care|October 2, 2019
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI networkMariavita Ciccarone, Stefan Hohaus, Alessandro Pulsoni, et al.
Leukemia & Lymphoma|March 8, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ studyAlessandra Tucci, Alessandro Re, Chiara Pagani, et al.
Pageof 6